Skin Cancer
New drug now available for actinic keratosis
Published in Biotech Week, March 28th, 2012
2012 MAR 28 -- A new topical gel now available by prescription significantly decreases the amount of time needed to treat actinic keratosis, a skin condition that is a common precursor to skin cancer, according to a multi-center trial led by researchers at Mount Sinai School of Medicine. The gel, called ingenol mebutate, is applied to the skin for just a few days, making it quicker and even more effective as current therapies require weeks to months to apply. The Phase III study results of the trial are published in the March 15, 2012 issue of the The New England Journal of Medicine.
Actinic keratoses are premalignant skin lesions very common in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
Source: Biotech Week (2012-03-28)
More Articles from Biotech Week
- Biotechnology
ATCC-U.Va. Collaboration to Foster Biotech Discovery - Biosensing
Chulalongkorn University Reports Research in Biosensing - University of Edinburgh
Clock gene helps plants prepare for spring flowering, study shows - Experimental Medicine
Data from Center for Biomolecular Science and Engineering Provide New Insights into Experimental Medicine - Synthetic Peptides
Data from Center for Genetic Engineering and Biotechnology Advance Knowledge in Synthetic Peptides - Synthetic Peptides
Data from Charite University Hospital and School of Medicine Provide New Insights into Synthetic Peptides - More from this issue of Biotech Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
